Bivassa 400mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Bevacizumab (400mg)
Overview Bivassa 400mg Injection
Oncaspar 400mg Injection is a cancer treatment drug indicated for colorectal cancer, non-small cell lung carcinoma, renal cell carcinoma, brain cancers, and gynecological malignancies (ovarian and cervical). Its mechanism involves angiogenesis inhibition, hindering tumor growth by restricting blood supply. Administered intravenously via infusion (either directly into a vein or through a surgically implanted port), Oncaspar 400mg Injection is a frequently utilized first-line treatment in combination therapies. Dosage and treatment length are determined by your physician, who will also monitor for infusion-related adverse events like hypertension and respiratory distress. Continued use depends on disease response and tolerability of side effects, a decision solely made by your oncologist. Regular monitoring of blood pressure and urinary protein levels may be recommended. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification to your surgeon is crucial, due to Oncaspar's potential to impair wound healing and increase bleeding risk; report any unusual bleeding immediately. Disclose current pregnancies, pregnancy intentions, or breastfeeding to your doctor. Comprehensive medication reconciliation with your healthcare provider is essential, as drug interactions are possible.
Uses of Bivassa 400mg Injection
Colorectal, ovarian, cervical, and kidney cancers; brain tumors; non-small cell lung carcinoma.
Major Benefits of Bivassa 400mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bivassa 400mg Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Bivassa 400mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bivassa 400mg Injection works:
Bivassa 400mg Injection is an anti-angiogenesis agent. Its mechanism of action involves inhibiting vascular endothelial growth factor (VEGF), thereby preventing the development of new blood vessels supplying tumors with essential oxygen and nutrients.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bivassa 400mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Bivassa 400mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Bivassa 400mg Injection while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Bivassa 400mg Injection may induce adverse reactions that could compromise driving capabilities. Drowsiness and syncope have been observed in patients receiving Bivassa 400mg Injection, potentially affecting safe driving.
KidneySAFE IF PRESCRIBED
The use of Bivassa 400mg Injection in patients with kidney disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Bivassa 400mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, medical advice is recommended.
What if you forget to take Bivassa 400mg Injection :
Omit a scheduled Bivassa 400mg Injection? Seek your physician's advice.
Facts to Know About Bivassa 400mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Actions | VEGF inhibitor |
3,018 People bought this recently